Letter: therapeutic trial is more informative than SeHCAT to diagnose bile acid malabsorption – authors' reply

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|42|6|781-781

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.42, Iss.6, 2015-09, pp. : 781-781

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Letter: therapeutic trial is more informative than SeHCAT to diagnose bile acid malabsorption

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 6, 2015-09 ,pp. : 780-780

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: HIV‐associated NAFLD – more questions than answers? Authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 9, 2015-05 ,pp. : 912-913

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: proton pump inhibitor‐responsive oesophageal eosinophilia – more than just gastro‐oesophageal reflux disease. Authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 44, Iss. 8, 2016-10 ,pp. : 912-913

John Wiley & Sons Inc

Access to resources Recommend Favorite

Authors' reply to letter by C. Steffen

By  

EUROPEAN JOURNAL OF PAIN (ELECTRONIC), Vol. 19, Iss. 7, 2015-08 ,pp. : 1051-1053

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: more studies are needed to elucidate the impact of HBV/HCV coinfection on cirrhosis and its consequences—Authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 543-544

John Wiley & Sons Inc

Access to resources Recommend Favorite